Welcome letter
Dr. Mohamed Babiker
President of MENA Congress for Neurogenetic Disorders 2025
Consultant Pediatric Neurology and Director of Pediatric Neurology Residency Program, Al Jalila Children`s Specialty Hospital
Clinical Associate Professor, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE
A very warm welcome to the 2nd MENA Congress for Neurogenetic Disorders.
It is with great pleasure that we invite you all to this one-of-a-kind conference in the region in its second edition building on the success of the first conference last year. The 1st MENA Congress for Neurogenic Disorders 2024 which was held on 15-16 November 2024 in Dubai, UAE, was the first regional conference that is fully detected to neurogenetic disorders. The first edition was very successful with 35 speakers, including 7 international experts, and more than 200 participants with more than 30% coming from other countries. Variable topics related to neurogenetics were discussed with 95% of attendees giving an above-average evaluation for the presentations.
The 2nd MENA Congress for Neurogenetic Disorders 2025 will take place on 17-18 October 2025 and will include experts, researchers, clinicians, and professionals from across the region and beyond gather here in Dubai to exchange knowledge, discuss advancements, and collaborate in the field of genetically-determined neurological disorders manifesting across the life span. This conference serves as a platform whereby clinical experiences are shared, basics but also emerging trends are tapped into whilst we collaborate towards better outcomes for our patients.
Throughout the event, we will hear from esteemed experts, engage in thought-provoking discussions, and explore innovative approaches to diagnosis, treatment, and management of neurogenetic disorders.
Let's join hands to make a positive impact on the lives of children and adults with neurogenetic disorders and that of their families too.
TOPICS COVERED
Genetics epilepsies
Neurodegenerative and white matter disorders
Movement disorders
Neurometabolic diseases
Neurodevelopmental disorders
Neuromuscular diseases
Updates on diagnostics
Advancements in therapeutics
PARTICIPANTS
Medical doctors from variable specialties and dentists
Nurses, dietitians, therapists, and genetic counselors
Pharmacists and laboratory personnel
Medical and medical sciences students
Researchers, scientists, and educators
Laboratories and pharmaceutical companies
Clinics and hospitals
Academic institutions